AEGISAEGISConsumer Alert & Verification
Official alertHighwp_page_registry

Amponsah- Effah Pharmaceuticals Limited

Published Jan 17, 2025Source

What we know

Summary Date Recall was issued:Product Name:Manufacturer:Recalling Firm:Batch(es):Manufacturing Date:Expiry Date:Reason for Recall: 11th December 2024Efpac TabletAmponsah- Effah Pharmaceuticals LimitedAmponsah- Effah Pharmaceuticals LimitedA2X266August 2022August 2025 This recall is necessitated as a result of an initial investigation that shows crystallization of the tablet which is an indication of high moisture content. AnnouncementThis recall is necessitated as a result of warehouse market surveillance conducted at the warehouse. Actual product specification is a powder for oral suspension. The affected batches were caked and not free flowing. This makes the product substandard and therefore not recommended for its intended use.

Safety advice

  • Stop using or purchasing the product if the notice asks you to.
  • Keep receipts, batch numbers and packaging — they help with returns or investigations.
  • Share this alert with anyone who might be affected, especially relatives and colleagues.
  • If you believe you’ve been harmed, contact the official source or a relevant authority.

Related advisories